Immix Biopharma, Inc. - IMMX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G | Eventide Asset Management, LLC | 5.6% | 3,891,019 | View |
| Aug 14, 2026 | SCHEDULE 13G | Finny Kuruvilla, M.D. Ph. D. | 5.6% | 3,891,019 | View |
| Aug 14, 2026 | SCHEDULE 13G | Robin C. John | 5.6% | 3,891,019 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP Ltd. | 14.0% | 9,783,192 | View |
| Jun 05, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 13.0% | 9,090,732 | View |
| May 15, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 9.1% | 4,802,002 | View |
| May 04, 2026 | SCHEDULE 13G/A | Millennium Management LLC | 3.3% | 1,750,200 | View |
| May 04, 2026 | SCHEDULE 13G/A | Millennium Group Management LLC | 3.3% | 1,750,200 | View |
| May 04, 2026 | SCHEDULE 13G/A | Israel A. Englander | 3.3% | 1,750,200 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.